Consortia

The Center plays a vital role as a convener, bringing together different elements of the life sciences ecosystem in Massachusetts to encourage new models of collaboration.

Massachusetts Neuroscience Consortium

Founded in the summer of 2012 and administered by the MLSC, the Massachusetts Neuroscience Consortium is a pioneering new model that is designed to leverage Massachusetts’ rich environment of neurobiology and neuroscience. Consortium members include Abbvie, Biogen Idec, EMD Serono, Janssen Research & Development, LLC, Merck, Pfizer and Sunovion Pharmaceuticals Inc. The consortium’s purpose is to accelerate early-stage research available to the pharmaceutical industry. By providing funding to premier primary investigations in the state, the consortium aims to introduce academic researchers to the challenges of targeted research and facilitate industry-academic collaborations.

A number of factors make this consortium unique:

  • Projects that receive funding are short-term and results-oriented. Milestones, budgets and objectives have been clearly defined by the industry sponsors.
  • Industry sponsors have identified common industry standards to inform the research and ensure compliance with established drug development protocols.
  • Industry sponsors will work in collaboration with principal investigators and their teams; sponsors also will contribute tools, data and other resources to the project teams to expedite their work.
  • Results developed by each principal investigator receiving funding will be shared among all of the consortium members. Industry sponsors will then determine their interest in validated targets as projects are completed.

In July, 2013 the Center announced the first seven awards under the consortium, including three focused on Alzheimer’s, two focused on neuropathic pain, and one each focused on muscular sclerosis and Parkinson’s Disease.

For more information about the program and how to apply, click here.

Massachusetts Biomanufacturing Roundtable

The Massachusetts Biomanufacturing Roundtable is a statewide organization supported by the MLSC to encourage and promote the growth of biomanufacturing in the Commonwealth and the New England region.

Members include leaders from all segments of Massachusetts’ biomanufacturing industry, academia and other key stakeholders. The Roundtable’s mission is to encourage technology innovation in biomanufacturing, talent development, infrastructure improvement and supportive government policies by improving communications, generating key industry data, and fostering collaborations. The Roundtable also serves as a forum for identifying specific initiatives that the MLSC can fund to promote biomanufacturing innovation in the Commonwealth.

View a brochure on biomanufacturing in Massachusetts »

Corporate Consortium

Through a suite of initiatives, including direct grants, loans and equity vehicles, the MLSC is identifying and making funds available to early-stage life sciences companies with a high-potential for technology commercialization, rapid growth and private equity financing. In order to leverage additional sources of capital and maximize support for its portfolio companies, the MLSC has developed a Corporate Consortium Program, which provides an opportunity for corporate and investment partners to contribute matching funds for the MLSC’s investments in early stage companies. The MLSC recognizes that one of its important value propositions for industry is to provide expedited access and an “early look” at new products and technologies that are under development in Massachusetts. Companies participating in the Corporate Consortium are given an opportunity to review the MLSC’s “deal flow” and to benefit from the assessments of that deal flow provided by the Center’s blue ribbon expert review panels.

In 2009, Johnson & Johnson’s Corporate Office of Science and Technology agreed to become the Consortium’s first member and provided $500,000 in grants to the MLSC over two years, which were pooled with the Center’s funds to support early stage companies in Massachusetts. In 2010, Sanofi Aventis U.S. joined and also provided $500,000 to the Consortium over two years.

The MLSC is currently seeking additional members to join the Corporate Consortium. Please contact Pamela Norton at pnorton@masslifesciences.com if you have any questions or would like more information.

Connect With Us

Facebook LinkedIn Twitter